© Rosalind Scientific LLC 2018-2022
© Rosalind Scientific LLC, 2018-2022
New Drug Hunter content, featured events and job postings straight to your inbox. Trusted by >3,500 drug hunters worldwide, unsubscribe anytime.
<< Back to November
oral CDK8 kinase inhibitor
effective in ovariectomized rat model
CDK8 identified as MoA after screen
Bioorganic & Medicinal Chemistry Letters
Daiichi Sankyo Co. Ltd.
7. The Daiichi Sankyo CDK8 kinase inhibitor, DS96432529, is intended to be a bone anabolic agent. The molecule shows preclinical efficacy and synergy with alendronate or parathyroid hormone. The discovery…
Ask your company or librarian about a Drug Hunter membership to to see all summaries and get access to even more helpful information.